Description: This article is the second installment in a three-part series on economic scenario generators (“ESGs”). Part I was published in the November 2019 issue. Part II addresses critical considerations in selecting, building, using, and validating ESGs. The article discusses key criteria in understanding ESGs including: - Risk factors - Scenario type - Process and parameterization - Calibration - Number of scenarios - Timing considerations

Description: Discusses the market, demographic, and macroeconomic factors that affect actuaries' choices for the assumptions they use in the pricing and valuation of many insurance products.

Description: Guidance and a model for actuaries to use when performing their professional services related to Medicaid (Title XIX) and Children’s Health Insurance Program (CHIP or Title XXI) managed care capitation rate setting.

Description: Occasionally, in the financial reporting world the stars align, and insurers get the opportunity to leverage their financial results and cashflows across multiple reporting use cases. Such opportunity came about with implementation of the U.S. generally accepted accounting practices (GAAP) long-duration targeted improvements (LDTI) accounting standard, that required companies to move away from locked-in assumptions for traditional life and limited-pay products and produce best estimate liability cashflows for these business lines.

Description: The instructors in this boot camp session will highlight the SOA's work on an updated Medicaid underwriting margin model. This research project includes an excel model, a set of instructions and a paper describing the key components of underwriting margin, including cost of capital and risk margin.

Description: "Direct medical costs for cancer care topped $209 billion nationally in 2020, accounting for a significant proportion of all health care expenditures in the U.S. Indirect costs are also significant, encompassing loss of productivity, wages, leisure time and decreased quality of life. The way cancer programs deliver and are reimbursed for care is rapidly changing. As the cost of cancer care continues to rise, several new value-based care programs - both public and private - have attempted to curb these rising costs. Learn about the current landscape of VBC oncology programs, several key challenges and opportunities with oncology analytics, as well as anticipated evolution of cancer care in the near future. Topics include: Current VBC oncology landscape, including a more detailed discussion on CMS' latest oncology program, Enhancing Oncology Model (EOM) Discussion on current challenges and opportunities with oncology analytics, including some advanced methodologies that have been developed based on documented clinical pathways to better understand cost drivers Future state of oncology care including emerging pharmaceuticals and novel therapies, personalized care regimens, and other clinical innovations"

Description: Join us for an Economic Outlook Panel that will explore topics like "what are markets saying about likelihood and severity or a recession?" and "how is inflation impacting investment decisions?" Our investment experts speaking at this panel have backgrounds in asset management, insurance and pensions and plan to speak on current macroeconomic trends and their impact on the market. Audience members will have the opportunity to participate and ask question during this live webcast. Prepare for a lively conversation with a panel focused on impacts of our economic environment.

Description: The SOA Research Institute’s Aging and Retirement Strategic Research Program and Canadian Institute of Actuaries are pleased to make available the first of two reports that look at Benefit at Risk (BaR) in lifetime pension pools.

Description: The primary purpose of this paper is to demonstrate, through a basic stochastic projection model, how inflation might impact savings and investing for retirement.

Description: The aftershocks of the COVID pandemic will pass --- eventually. Government subsidies and spending soared in 2020 to meet the challenges of the pandemic. Health expenditures leapt from 17.6% of GDP to 19.7%, and then dropped to 18.8% in 2021, and will fall again to 18.2% (projected) in 2022, but are expected to return to the long-run trend by 2024 and gradually rise thereafter. However, during the next few years most attention will be paid to dealing with complex aftershocks from the flood of Covid funding in 2020 and 2021, a surge of inflation in 2022, and a looming recession in 2023.